Anti ganglioside monoclonal antibodies

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435330, 4241301, 4241371, 4241381, 4241411, 5303871, 5303875, 5303877, 5303881, C12N 512, A61K 39395, C07K 1630

Patent

active

058175130

ABSTRACT:
The present invention relates to immunotherapy strategies for the treatment of malignancies. The present immunotherapy strategies have gangliosides as a target. Gangliosides are glycosphingolipids which are present on normal cells and on malignant cells. On malignant cells they are more abundant and expressed in a different organization and conformation. The present invention provides antibodies which recognize these gangliosides, which antibodies are specific, have recurrent idiotypes and have value as immunoregulators. The invention further provides anti-idiotypic antibodies against anti-ganglioside antibodies. These are useful in vaccination strategies.

REFERENCES:
Article entitled: IgM-Induced Specific Antibody Responses: Direct Correlation between Responsiveness and Natural or Induced Recurrence of the Idiotype. Authors: F. Ivars, D. Holmberg, P.-A. Cazenave & A. Coutinho -Published in Scand. J. Immunol. 17, 231-240, 1983.
Article entitled: Perturbation of the Autoimmune Network. Authors: Maurizio Zanetti, Denis Glotz and Joy Rogers -Published in The Journal of Immunology vol. 137, 3140-3146, No. 10, Nov. 15, 1986.
Article entitled: Activation of a Functional Idiotype Network Response by Monoclonal Antibody Specific for a Virus (M-MuLV)-Induced Tumor Antigen. Authors: Thomas J. Powell, Jr., Richard Spann, Meenal Vakil, John F. Kearney and Eddie W. Lamon -Published in the Journal of Immunology, vol. 140, 3266-3272, No. 9, May 1, 1988.
Article entitled: In Vivo Effects of Antibodies Against a High Frequency Idiotype of Anti-DNA Antibodies in MRL Mice. Authors: Dvora Teitelbaum, Joyce Rauch, B. David Stollar and Robert S. Schwartz -Published in The Journal of Immunology, vol. 132, No. 3, Mar. 1984.
Article entitled: Anti-Idiotype Monoclonal Antibody Carrying the Internal Image of Ganglioside GM3. Authors: Saburo Yamamoto, Toshiko Yamamoto, Romaine E. Saxton, Dave S. B. Hoon, Reiko F. Irie -Published in the Journal of the National Cancer Institute, vol. 82, No. 22, Nov. 21, 1990.
Article entitled: Thymus-Dependent Antiidiotype and Anti-Antiidiotype Responses to a Dinitrophenyl-Specific Monoclonal Antibody. Authors: Julie G. Baskin, Tom M Ryan, Meenal Vakil, John F. Kearney and Eddie W. Lamon -Published in The Journal Of Immunology, vol. 145, 202-208, No. 1, Jul. 1, 1990.
Article entitled: The Participation of B Cells and Antibodies in the Selection and Maintenance of T Cell Repertoires. Authors: C. Martinez-A, P. Pereira, M.L Toribio, M.A.R. Marcos, A. Bandeira, A. De La Hera, C. Marquez, P.-A. Cazenave & A. Coutinho -Published in Immunological Reviews 1988, No. 101.
Article entitled: Phase I Trial of the Murine Monoclonal Anti-G.sub.D2 Antibody 14G2a in Metastatic Melanoma. Authors: Mansoor N. Saley, M.B. Khazaeli, Richard H. Wheeler, Edward Dropcho, Tiepu Liu, Marshall Urist, Donald M. Miller, Sharon Lawson, Pam Dixon, Charles H. Russell, and Albert F. LoBuglio -Published in Cancer Research 52, 4342-4347, Aug. 15, 1992.
Article entitled: Mouse Monoclonal IgG3 Antibody Detecting G.sub.D3 Ganglioside: A Phase I Trial in Patients with Malignant Melanoma. Authors: Alan N. Houghton, David Mintzer, Carlos Cordon-Cardo, Sydney Welt, Bettina Fliegel, Saroj Vadhan, Elizabeth Carswell, Myron R. Melamed, Herbert F. Oettgen, and Lloyd J. Old -Published in Proc. Natl. Acad. Sci. USA, vol. 82, pp. 1242-1246, Feb. 1985.
Article entitled: Humoral Immune Response in Disease-Free Advanced Malanoma Patients After Vaccination with Malanoma-Associated Gangliosides. Authors: Jacques Portoukalian, Stefan Carrel, Jean-Francois Dore and Philip Rumke -Published in Int. J. Cancer; 49, 893-899 (1991).
Article entitled: Active Specific Immunotherapy in the Treatment of Patients with Cancer. Author: Philip Livingston, MD -Published in Immunology and Allergy Clinics of North America, vol. 11, No. 2, May 1991.
Article entitled: Analysis of the Expression of N-Glycolylneuraminic Acid-Containing Gangliosides in Cells and Tissues Using Two Human Monoclonal Antibodies. Authors: Koichi Furukawa, Hiroshi Yamaguchi, Herbert F. Oettgen, Lloyd J. Old and Kenneth O. Lloyd Published in The Journal of Biological Chemistry, vol. 263, No. 34, Issue of Dec. 5, pp. 18507-18512, 1988.
Article entitled: Detection of Gangliosides as N-Glycolyincuraminic Acid-specific Tumor-associated Hanganutziu-Deicher Antigen in Human Retinoblastoma Cells. Authors: Hideyoshi Higashi, Tetsuo Sasabe, Yukio Fukui, Morimasa Maru and Shiro Kato -Published in Jpn. J. Cancer Res. (Gann), 79, 952-956, Aug. 1988.
Article entitled: Density-Dependent Recognition of Cell Surface GM.sub.3 by a Certain Anti-Melanoma Antibody, and GM.sub.3 Lactone as a Possible Immunogen: Requirements for Tumor-Associated Antigen and Immunogen. Authors: Gustave A. Nores, Taeko Dohi, Masaru Taniguchi and Sen-Itiroh Hakomori -Published in The Journal of Immunology, vol. 139, 3171-3176, No. 9, Nov. 1, 1987.
Article entitled: Aberrant Glycolylation in Cancer Cell Membranes as Focused on Glycolipids: Overview and Perspectives. Author: Sen-itiroh Hakomori -Published in Cancer Research, vol. 45, 2405-2414, Jun. 1985.
Tai et al, JBC, 1987, 262:6803-6807.
Sikorska, J. Biol. Resp. Mod., 1988, 7:327-358.
Johnstone & Thorpe (Immunochem in Practice, Blackwell Scientific Publ, Oxford, 1987, pp. 49-50.
Queen et al. PNAS vol. 86 pp. 10029-10033 1989.
Vick et al. Acta Cytologica 1992. vol. 36 (5) p. 697.
Miyake et al. Cancer Research V. 48 6154-6160 1988.
Shitara et al. Journal of Immunological Methods V. 169 83-92 1994.
Kannagi et al. Japanes Journal of Cancer and Chemotherapy vol. 16 No. 3 1989. p. 679.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti ganglioside monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti ganglioside monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti ganglioside monoclonal antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-76237

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.